Skip to main content
Back to feed
HealthConfirmedMedium
10.0

AstraZeneca targets $80 billion annual revenue by 2030 driven by oncology portfolio

AstraZeneca CEO Pascal Soriot reaffirmed the company's $80 billion revenue goal for 2030, citing strong performance in its oncology segment. While recent quarterly growth supports this trajectory, the firm faces ongoing challenges from recent R&D setbacks.

Börsen-Zeitungabout 7 hours agoGBCredibility 48%View source

Score Breakdown

Mosaic Score10.0
Confidence0.9
Significance0.5
Source credibility0.5

Intelligence Tags

#astrazeneca#oncology#pharmaceuticals#revenue#biotech

Locations

Cambridge

Entities

country
Source

Related signals

8 found